Skip to main content
LIFECOME BIOCHEMISTRY CO., LTD. logo

LIFECOME BIOCHEMISTRY CO., LTD. — Investor Relations & Filings

Ticker · 002868 ISIN · CNE100002QH2 LEI · 65560089EP03NANEN790 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,742 across all filing types
Latest filing 2024-09-06 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002868

About LIFECOME BIOCHEMISTRY CO., LTD.

https://www.pclifecome.com

Lifecome Biochemistry Co., Ltd. focuses on the research, development, and large-scale production of fermentation-based veterinary pharmaceuticals and feed additives. The company’s core product portfolio includes Bacitracin Zinc, Bacitracin Methylene Disalicylate (BMD), and Colistin Sulfate, available in both active pharmaceutical ingredient (API) and premix forms. These biochemical products are primarily utilized in the livestock and poultry sectors to manage enteric health and improve feed efficiency. The organization operates advanced fermentation and purification facilities, maintaining compliance with international Good Manufacturing Practices (GMP) and various global regulatory standards. By leveraging specialized biotechnological processes, the company provides high-purity solutions aimed at enhancing animal nutrition and disease prevention across international markets.

Recent filings

Filing Released Lang Actions
关于控股股东部分股票解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the controlling shareholder of the company. It details the number of shares released from pledge, the dates, and the impact on shareholding. There is no financial statement, no report attached or referenced as being published, and no mention of earnings, management changes, or other report types. The document is a regulatory announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it does not fit other more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short (1564 characters), and it is a standalone announcement about share pledge release.
2024-09-06 Chinese
第五届董事会第六次（临时）会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a board meeting resolution by the company 绿康生化股份有限公司. It details the approval of a loan secured by company-owned assets, including the meeting attendance, voting results, and legal compliance statements. There is no financial report, earnings data, or detailed financial analysis present. The document is an official announcement of a board decision, specifically about financing via asset mortgage, but it is not a full capital/financing update report. It is a board resolution announcement related to financing but does not contain comprehensive financing details or financial statements. Given the content and nature, the best fitting category is 'Capital/Financing Update' (CAP), as it announces a financing-related board decision. The document length is short and focused on a specific financing approval, not a full report or regulatory filing. Confidence is high due to clear keywords like '董事会会议决议公告' (board meeting resolution announcement), '抵押贷款' (mortgage loan), and the detailed voting results on financing matters.
2024-09-06 Chinese
关于公司以自有资产抵押向银行申请贷款的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by the company regarding its application for a bank loan secured by its own assets. It details the loan amount, collateral information, board meeting approval, and the purpose and impact of the loan. There are no financial statements or detailed financial data presented. The document is a financing update related to capital structure and funding activities. It is not a full financial report, earnings release, or regulatory certification. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and focused on financing, not a report publication or regulatory filing.
2024-09-06 Chinese
关于公司自有资产解除抵押的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the release of a company's own asset from mortgage (解除抵押). It references previous announcements about asset mortgage but focuses on the update that the mortgage has been lifted. The document is brief (653 characters) and does not contain financial statements or detailed financial data. It is an official notice about a capital-related event (asset mortgage release), which fits best under Capital/Financing Update (CAP).
2024-09-05 Chinese
关于控股股东部分股票质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the proportion of total shares, pledge dates, and related risk disclosures. There is no financial statement, earnings data, or management discussion. The document is a regulatory disclosure about share pledging, which fits the category of a Regulatory Filing (RNS) as it does not fall under more specific categories like Major Shareholding Notification (MRQ) or Transaction in Own Shares (POS), since it concerns pledged shares rather than share ownership changes or buybacks. The document length is short (1734 characters), and it is a direct announcement, not a report or presentation. Therefore, the best classification is Regulatory Filings (RNS).
2024-09-04 Chinese
简式权益变动报告书（杭州皓嬴）
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report" or "Equity Change Report". It details the increase in shareholding by an entity (杭州皓赢投资合伙企业) acquiring 5% of the shares of 绿康生化股份有限公司 through an agreement transfer. The document includes legal references to Chinese securities laws and regulations governing equity changes, detailed information about the shareholder, the transaction, and compliance procedures. There is no indication that this is an annual report, earnings release, or any other financial report. Instead, it is a formal disclosure of a change in major shareholding. This fits the definition of "Major Shareholding Notification (Code: MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds such as 5%. The document length and content confirm it is the report itself, not just an announcement or certification, so it is not RPA or RNS.
2024-08-30 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.